ACE2 and COVID-19: Cytokine storms and pneumonia may be increased as a result of the deregulation of ACE-2 induced by SARS-CoV-2, and blocking the upstream regulation mir-125b-5p could provide a novel strategy to manage COVID-19 (Figure 6) (Morassi et al., 2020).